QT prolongation associated with azithromycin/amiodarone combination

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 10, 2001, Pages 1572-1574

  Samarendra, P ^a   Kumari, S ^a   Evans, S J ^a   Sacchi, T J ^a   Navarro, V ^a  

^a NONE   (United States)

Author keywords

Azithromycin; Erythromycin; QT dispersion; QT interval; Torsades de pointes

Indexed keywords

AMIODARONE; AZITHROMYCIN; ENALAPRIL; ERYTHROMYCIN; FUROSEMIDE;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CARDIOTOXICITY; CASE REPORT; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG SAFETY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ARRHYTHMIA; HEART REPOLARIZATION; HUMAN; PNEUMONIA; QT INTERVAL; TORSADE DES POINTES;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; TIME FACTORS;

EID: 0034776611     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.01572.x     Document Type: Article

References (12)

1. Amiodarone and torsade de pointes in patients with advanced heart failure
2. The QT interval: A predictor of the plasma and myocardial concentrations of amiodarone
3. Intravenous amiodarone: An effective antiarrhythmic agent
4. Amiodarone and post-MI patients
5. Effect of amiodarone, sematilide and sotalol on QT dispersion
6. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone
7. The historical development, cellular electrophysiology and clinical pharmacology of amiodarone
8. A general overview of amiodarone toxicity: Its prevention, detection and management
9. Late" proarrhythmiadue to quinidine
10. Cellular and ionic mechanism underlying erythromycin induced long QT intervals and torsade de pointes
11. Cardiac actions of erythromycin: Influence of female sex